ARI Leverages a Unique Infrastructure to Provide a Full Continuum of Pharma Services
With locations nationwide, we provide you, our clients, with an unparalleled level of access, expertise, flexibility, and scalability. Our local and regional presence in the hospitals and the communities we serve allows us to offer go-to-market business models and solutions that extend beyond the research lab and into the community, aiding your commercialization process.
What Makes ARI Different?
|
|
Pre-Clinical and Clinical Trial Services
- Customized and IRB-approved human biomaterials from a national network and specialty physicians
- Access to board-certified pathologists providing consultation and interpretation services, to support your product development program and companion diagnostic discovery efforts
- 800+ technical laboratory technicians
- Dedicated clinical research coordinators across multiple states and healthcare systems
- Wide variety of available testing platforms
- Extensive IHC, FISH, and molecular test menus
- Assay Validation Services
- Method comparison study capability using multiple platforms
- Interlaboratory reproducibility study capabilities
- Specimen and data management
- Custom specimen kits
- Project management services
- Customized digital pathology imaging and annotation services
Post-Trial Support and Product Launch
- Nationwide lab locations to support the launch of the CDX
- National salesforce to drive adoption and knowledge of the CDX
- Dedicated marketing team to support commercial efforts
- Pathologists can educate local clinicians on new CDX testing through tumor boards and local meetings
- Data analytic services
Lab Testing Services:
- Sanger sequencing
- Next-generation sequencing
- PCR-based assays
- Viral genotyping
- Immunohistochemistry
- Image analysis
- Fluorescence in situ hybridization
- Flow cytometry
- Chromosome analysis
- Data services